Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

The patch effectively promotes hair growth for alopecia areata without pain.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Ritlecitinib effectively regrows hair in treatment-resistant alopecia areata with mild side effects.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Anifrolumab helped a woman with severe lupus achieve remission when other treatments failed.

Tazarotene gel may be more effective for acne than adapalene gel.

Scalp medⓇ effectively and safely improves hair growth in men with androgenetic alopecia.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

The inhibitor affects androgen metabolism but not ovarian function.

The treatment is effective and safe for severe alopecia areata in children, but not for total or universal hair loss.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Ebastine may help regrow hair in alopecia areata patients.

Apremilast showed mixed results for treating severe alopecia areata.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Dupilumab helps children with alopecia areata regrow hair safely.

Tofacitinib may work better than methotrexate for treating moderate-to-severe alopecia areata.